文献速递脑血管病外科神经重症

病前高血压控制对动脉瘤性蛛网膜下腔出血患者结局的影响

Effect of premorbid hypertension control on outcome of patients with aneurysmal subarachnoid hemorrhage.
PubMed 文献 · Acta Neurochir (Wien) · 2018-10-12

该研究回顾性分析了2012年2月至2017年12月期间本院收治的348例动脉瘤性蛛网膜下腔出血患者,根据病前高血压病史及降压药使用情况分为降压组和未控制组。结果显示,病前高血压控制与患者较好的临床结局相关,使用ACEI类或ARB类降压药与动脉瘤破裂后出血量较少相关。

要点

  • 病前高血压控制与动脉瘤性蛛网膜下腔出血患者较好的临床结局相关。
  • 使用ACEI类或ARB类降压药与动脉瘤破裂后出血量较少相关。
  • 病前未控制高血压患者临床分级更差,更易出现严重蛛网膜下腔出血和脑内血肿。

核心结论

  • 病前高血压控制与动脉瘤性蛛网膜下腔出血患者较好的临床结局相关。
  • ACEI类或ARB类降压药与动脉瘤破裂后出血量较少相关。

研究设计与样本

  • 回顾性分析2012年2月至2017年12月本院收治的348例动脉瘤性蛛网膜下腔出血患者的临床资料。
  • 根据病前高血压病史及降压药使用情况,将患者分为降压组和未控制组。

主要发现

  • 与病前高血压控制患者相比,病前未控制高血压患者临床分级更差,蛛网膜下腔出血更严重,脑内血肿更常见。
  • 降压组中使用ACEI类或ARB类药物治疗的患者动脉瘤出血量较少,而未控制组中3级高血压患者动脉瘤出血量较多。
  • 病前高血压控制患者再出血、脑积水和脑血管痉挛发生率较低,残疾率和死亡率较低。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Hypertension is common in patients with aneurysmal subarachnoid hemorrhage (SAH). However, it is still unclear whether premorbid antihypertensive therapy can help to reduce the risk of severe aneurysmal bleeding. Therefore, this study aims to assess the effect of premorbid hypertension control on outcome of patients with aneurysmal SAH. METHODS: We retrospectively reviewed the clinical data of patients with intracranial aneurysms admitted to our institution from February 2012 to December 2017. Based on premorbid hypertension history and use of antihypertensive agents, all patients with aneurysmal SAH were divided into antihypertensive group and uncontrolled group. Patient characteristics, imaging features, clinical complication, and outcome were analyzed between the two groups. RESULTS: A total of 348 patients with ruptured aneurysms were included in this study. Compared to those with premorbid controlled hypertension, patients with premorbid uncontrolled hypertension presented worse clinical grade, with more severe aneurysmal SAH and more frequent intracerebral hematoma. Patients receiving a treatment for ACEI type or ARB type of drugs in the antihypertensive group suffered from less amount of aneurysmal bleeding, while patients with grade 3 hypertension in the uncontrolled group suffered from more amount of aneurysmal bleeding. Patients with premorbid controlled hypertension had a lower incidence of rebleeding, hydrocephalus, and cerebral vasospasm, and had a lower rate of disability and mortality. CONCLUSIONS: Premorbid hypertension control is associated with favorable clinical outcome of patients with aneurysmal SAH. Besides, the ACEI type or ARB type of antihypertensive agents is associated with the less amount of bleeding after aneurysm rupture.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Zheng J, Xu R, Liu G, et al. Effect of premorbid hypertension control on outcome of patients with aneurysmal subarachnoid hemorrhage. Acta Neurochir (Wien). 2018. PMID: 30315363. doi:10.1007/s00701-018-3699-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。